Fv-4 is a mouse gene that dominantly confers resistance to infection by ecotropic murine leukemia virus IMuLV). We previously demonstrated that mixed radiation bone marrow chimeras containing Fv-l'-bearing BALBlc-Fv-4W' (C4W) bone marrow and Fv-4"bearing C3H/He (C3H) bone marrow grafted into C3H recipient mice lC4W + C3H + C3H)
were resistant to Friend leukemia virus lFLV)-induced leukemogenesis, even when they contained as high as 70% C3H-derived cells. This indicates that FLV-sensitive C3H-derived cells are rendered refractory to infection and/or transformation with FLV when they coexist in mice with Fv4-bearing cells. To investigate the mechanism of Fv-4 resistance to FLV-induced leukemogenesis, we first examined the expression of Fv-l' env antigen in the peripheral blood mononuclear cells (PBMC) of these chimeras. The Fv-4' env antigen was present not only on C4W-derived cells, but also on Fv-4'-bearing C3H-derived cells in C4W + C3H -+ C3H mixed bone marrow chimeras. The Fv-4' env antigen that binds to the cell surface of C3H cells was found in sera from normal RIEND LEUKEMIA virus (FLV)-induced leukemogenesis is controlled by many host genes including Fv-l*, Fv-2' ' : F V -~~~, Fv-4"/: Fv-5"/: Fv-6, Rfv-I"/: Rfv-2"/: Rfv-3"/', some of which are closely linked to the mouse major histocompatibility complex (MHC), H-Z. ' .' Among them, the resistance allele at the Fv-4 locus (Fv-43, located on mouse chromosome 12, is dominant over the susceptibility allele ( F v -~" )~ and confers strong resistance to infection with ecotropic retroviruses, as well as to retrovirus-induced turn or^.^.^
A unique cell surface protein immunologically related to ecotropic murine leukemia virus (MuLV) envelope glycoprotein gp70, has been identified in normal Fv-4' m i~e .~.~ Further, the Fv-4'-associated, MuLV-related sequence has been cloned and its structure has been shown to be identical to that of the 3' portion of a provirus genome extending from the end of the pol gene through a complete env gene to a 3' long terminal repeat.',' Mouse cells transfected with this putative Fv-4' gene expressed a circa 3-kb Fv-4 env RNA, which is comparable to the size of a message expressed in mice carrying the Fv-4' trait. NIH3T3 cell lines transfected with the cloned Fv-4 env gene expressed a cell surface Fv-4'-specific MuLV envelope protein and were variably resistant to superinfection with ecotropic MuLVs.' More recently, transgenic mouse strains carrying the Fv-4 env gene, which was placed under control of its presumed natural promoter, were shown to be completely or partially resistant to infection with Friend MuLV. The resistance correlated with the level of expression of transgene RNA and its translated protein.
" A viral interference model has been proposed for the mechanism of Fv-4"related restriction of MuLV infeccells chronically infected with one virus are resistant to superinfection with other viruses bearing the same virus envelope specificity." Interference is probably due to blockage of virus receptors by the envelope protein of the initially infecting virus.' Thus, the interference model suggests that the Fv-4' env antigen competes with ecotropic MuLV for cell surface receptors. However, the exact mechanism for the virus interference controlled by Fv-4' is still undetermined.
We have been developing a model to test the potential of bone marrow transplantation to cure retrovirus-induced disease. Bone marrow cells from BALBIc-Fv-4W (C4W) mice were mixed with FLV-susceptible C3H/He (C3H, Fv-$")-derived bone marrow cells in various proportions and were transplanted into supralethally irradiated C3H hosts (C4W + C3H -+ C3H). We found that C4W + C3H + C3H mixed chimeras that contained up to 70% C3H-derived cells, were refractory to FLV-induced leukemogenesis." Here we show that in the mixed chimeras the Fv-4' env antigen was released from C4W-derived cells into the serum and bound to C3H-derived cells, presumably via ecotropic MuLV receptors. When the amount of Fv-4' env antigen was sufficient to saturate virus receptors, the mixed bone marrow chimeras were protected from infection with exogenous FLV.
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MATERIALS AND METHODS
Mice. Specific-pathogen-free (SPF) C3HMeMsNrs (C3H, Fv-4', H-2') male mice were bred from our colonies at the Animal Production Facility of this institute and were maintained within the clean conventional animal facility in which all animals are maintained SPF by our criteria.I3 BALBk-Fv-4W (C4W, Fv-4, H-2") mice, which are Fv-4 congenic with BALB/c mice (Fv-4'), were originally provided by Dr T. Odaka (Professor Emeritus, Tokyo University, Tokyo, Japan)I4 and were maintained in our laboratory.
Preparation of mixed radiation bone marrow chimeras and virus infection. Ten-to 12-week-old C3H mice were irradiated with 12.5 Gy of I3'Cs gamma-rays from GAMMA-CELL-40 (Atomic Energy of Canada, Ltd, Kanata, Canada) at a dose rate of 0.60 G y h i n .
Mixed radiation bone marrow chimeras (C4W + C3H + C3H) were constructed by grafting a mixture of bone marrow cells from C4W and C3H donors as described earlier.I5 Four groups of mixed radiation bone marrow chimeras were produced: C3H mice that were supralethally irradiated and reconstructed with a mixture of ( I ) I X IO' bone marrow cells from C4W and 2 X 10' cells from C3H mice Staining for Fv-4' env antigen. To assess the expression of Ft.-4' env antigen, cell surface immunofluorescence analysis was performed on the PBMC taken from the tail vein of individual mixed bone marrow chimeras. For immunofluorescence analysis of cell surface antigens, PBMC were stained with fluorescein isothiocyanate (F1TC)-conjugated monoclonal anti-H-2p antibody (Meiji Institute of Health, Tokyo, Japan) and biotin-conjugated monoclonal antibody (MoAb) to Fv-4' env antigen (anti-Fv-l' MoAb), followed by phycoerythrin (PE)-conjugated streptavidin. The specimens were also stained with FITC-conjugated anti-H-2D" antibody (Meiji Institute of Health) and biotin-conjugated anti-Fv-YMoAb, followed by PEconjugated streptavidin. Anti-Fv-4' MoAb was kindly provided by Dr H. Sato (Sapporo City Hospital, Sapporo, Japan). Two-color fluorescence analysis was performed on a FACScan (Becton Dickinson, Mountain View, CA).
Assuy for surjace binding of Fv-4 env antigen. Thymocytes and spleen cells from C3H mice, which are susceptible to ecotropic MuLVs, were used for the binding of Fv-4' env antigen. Cell suspensions were prepared from thymus or spleen of C3H mice. A total of 1 X IO6 thymocytes or spleen cells from C3H mice were washed three times with RPMI 1640 medium and incubated with 100 p L of RPMI 1640 medium containing 20% mouse serum from C3H, C4W, C4W + C3H, or C4W + C3H + C3H mice for l hour at 4°C. The cells were then washed three times with phosphate-buffered saline (PBS) and stained with biotin-conjugated anti-Fv-4' MoAb and FITC-conjugated anti-H-2p antibody followed by PE-conjugated streptavidin. The expression and/or adherence of Fv-4' env antigen on the surface of H-ZK"-positive C3H cells was measured by immunofluorescence analysis using a cell sorter. The expression of F\>-4' env antigen on the surface of thymocytes and spleen cells from C4W mice served as positive controls. The cells of each experimental group were mixed only with PE-conjugated streptavidin and measured ab negative controls. The specificity of binding of env antigen to viral receptors was determined using mink lung cells that do not express the ecotropic MuLV receptor and mink lung cells transfected with the ecotropic MuLV receptor gene","; the latter were kindly provided by Professor A. Ishimoto (Institute of Virus Research, Kyoto University, Kyoto, Japan).
Concentration of the virion-contuining .fraction r f FLV solution us well as C4W serum by centrifugation. To determine whether or not the Fv-4' env antigen were secreted in virions, C4W serum was centrifuged at 15,000 rpm (1 6,0008) at 4°C for more than 2 hours to pellet virus. We assessed the ability of pellet and supernatant fractions to bind to C3H thymocytes and confer expression of Fv-4' env antigen on the cell surface. The pellet fraction plus approximately 5 pL of supernatant was diluted with PBS to the original volume (500 pL). Under the experimental conditions employed, virus particles in the serum of C4W mice are expected to be pelleted." To confirm that virus particles were precipitated under these conditions, an FLV solution that was prepared as described earlier"' was similarly centrifuged, and the pellet resuspended with PBS as above. After filtration through 0.22 p n Millipore filters. these holutions were incubated with C3H thymocytes for 1 hour at 4°C. The binding of Fv-4' env antigen or FLV to C3H thymocytes was then determined using biotin-conjugated anti-Fv-4' MoAb or polyclonal anti-MuLV antibody (Cell Science Laboratory, Silver Spring, MD) by fluorescence-activated cell sorter (FACS) analysis.
Fv-4' serum inhibition of FLV binding of C3H cells. A total o f 1 X 10' C3H thymocytes or spleen cells were incubated with C4W serum for 30 minutes at 4°C and 0.1 mL of FLV was added. After another 30 minutes at 4"C, the cells were washed three times with PBS. Expression of MuLV antigen on the surface of test cells was assessed by immunofluorescence staining and flow cytometric analysis as described above. Inhibition of FLV binding to C3H cells by these products was determined by comparing the cell surface expression of MuLV antigens on C3H cells that were preincubated with C3H or C4W serum. As negative controls, C3H cells that were not incubated with FLV, and C4W cells incubated with FLV were also examined for cell surface expression of MuLV antigens.
RESULTS
Susceptibility of C4W + C3H + C3H mixed radiation bone marrow chimeras to FLV-induced leukemogenesis depends on percentage of C4W-derived cells. We previously found" that C4W + C3H + C3H mixed chimeras that contained over 30% C4W-derived (H-Zd antigen-positive) peripheral blood cells were resistant to infection with FLV. In the present experiments (Fig l) , C4W + C3H mice were completely resistant to FLV-induced leukemogenesis, although two mice died from unknown causes other than leukemia about 200 days after inoculation with FLV. Mixed chimeras that contained less than 15% C4W-derived cells [C4W(2) + C3H(10) + C3H and C4W(1) + C3H(9) + C3H] were susceptible to FLV. C4W(5) + C3H(5) -+ C3H chimeras had different survival depending o n the percentage of C4W-derived cells: chimeras containing 25% to 35% C4W-derived cells were resistant to FLV-induced leukemogenesis (one mouse died accidentally during blood sampling, but was free from leukemia), while chimeras containing 15% to 25% C4W-derived cells were susceptible to FLV. Thus. these results generally confirm our previous observations. + C3H chimeras contained 30% to 43% and the PBMC of C4W(2) + C3H(10) + C3H chimeras contained 5 % to 9% C4W-derived cells. The PBMC from C3H + C3H mice and C4W + C3H chimeras contained more than 95% H-2'-positive and H-2"-positive cells, respectively. Two-color flow cytometric analysis showed, as expected, that PBMC of C3H -P C3H mice were H-2'-positive, but negative for Fv-4' env antigen (Fig 2A) . Also, as expected, C4W-derived (H-T'-positive) cells of mixed chimeras were positive for Fv-4' cnv antigen. Unexpectedly, the majority of C3H-derived (H-2'"positive) PBMC of C4W(IO) + C3H(2) + C3H mixed chimeras were also positive for Fv-4' env antigen (Fig 2B) . The C3H-derived (H-2'-positive) PBMC of C4W(IO) + C3H(2) + C3H and C4W(2) + C3H( IO) + C3H mixed chimeras had lower levels of Fv-4' antigen than C4W + C3H chimera mice (positive control) (Fig 3A) . (Fig 3B) .
Chronological changes in the mean intensity of Fv-4' env antigen on C3H-derived PBMC of mixed chimeras after bone marrow transplantation and after inoculation with FLV are shown in Fig 4. The amount of Fv-4' env antigen was high 1 month after bone marrow transplantation and decreased slightly 2 to 3 months after bone marrow transplanta-
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FLV -2W For personal use only. on October 22, 2017. by guest www.bloodjournal.org From Table 1) . The same type of experiments using C3H spleen cells showed similar results. These data demonstrate that C4W-derived serum contains a detectable amount of Fv-4' env antigen that can bind to the surface of C3H-derived cells. 
Binding of serum Fv-4' env antigen to ecotropic MuLV receptor.
To further analyze the binding specificity of Fv-4' env antigen in C4W serum, we made use of a mink cell line transfected with DNA encoding the ecotropic MuLV receptor and parent mink cells that did not express ecotropic MuLV receptors. Fv-4' env antigen present in C4W serum bound to the transfected cells (Fig 5, curve a) , but not to the parental cells (Fig 5, curve b) , as would be expected if the Fv-4' env antigen was binding to the ecotropic virus receptor. Form of Fv-4' env antigen in C4W serum. The possibility that the Fv-4' env antigen in serum was associated with virus particles was investigated by centrifugation to pellet virus.'' Fv-4' env antigen from C4W serum was found in the supernatant fraction, but not in the sediment fraction, when assessed by binding to C3H thymocytes (Fig 6A) . In contrast, most FLV antigen in an FLV solution was pelletable, although a small amount of FLV antigen was also found in the supernatant fraction (Fig 6B) . FLV antigen in serum from FLV-infected C3H mice gave similar results (data not shown). These results imply that the Fv-4' env antigen in the serum is not associated with virions.
Serum Fv-4' env antigen can block binding bv FLV. We previously suggested that Fv-4 resistance may be mediated via receptor interferen~e."'.~ To test whether the binding of Fv-4' env antigen from serum interferes with FLV adsorption, C3H thymocytes or spleen cells were preincubated with C4W serum, followed by incubation with FLV suspension. A large amount of FLV antigen was bound to the cell surface of C3H thymocytes or spleen cells if the cells were preincubated with C3H serum (Fig 7, curve a) , whereas preincubation with C4W serum strongly reduced the binding of FLV (Fig 7, curve b) . Negative controls included C4W cells incubated with FLV (Fig 7, curve c) and C3H cells not incubated with FLV (Fig 7, curve d) .
DISCUSSION
MuLV infection is initiated by binding of virus envelope to membrane receptors expressed on susceptible cells. Binding is required for fusion of the virus envelope to the target cell, an event that may occur at the cell surface or within an acidified endosome after receptor-mediated endocytosis that results in entry of the virion core into the cytoplasm and initiation of
The mechanism of Fv-4 resistance is presumed to be mediated via receptor interference s. 1.9 . This virus interference model is related to the phe- (Fig 5) and, further, that binding of Fv-4' env antigen to the cell surface receptors interferes with the subsequent binding and infection by FLV (Fig 7) .
The interference appears to be a consequence of the modification of virus receptor via interaction between receptor and viral envelope glycoprotein.2s.2h Experiments demonstrating interference have usually been done in persistently infected cells. Recent findings suggested that, in those cells, intracellular binding of receptor by env glycoprotein induces downregulation of cell surface receptor molecules. A study with reticuloendotheliosis virus shows that envelope mutants that are retained predominantly in the endoplasmic reticulum (ER) can still cause superinfection interferen~e.~' Related studies using the mutant env gene of a newly cloned MuLV showed that the mutant env glycoprotein that remained in the ER caused superinfection resistance. Transfection of the mutant env gene into cells persistently infected with wildtype virus of the same interference group led to trapping of the wild-type env protein in the ER and suppressed expression of wild-type virus.2* The interference demonstrated in this paper is different from the interference shown in persistently infected cells in that the binding of Fv-4' env antigen from outside uninfected cells blocked the attachment and replication of infecting virus. Such a phenomenon has not been reported in other retroviruses. Human immunodeficiency virus (HIV) binding to susceptible cells failed to induce receptor (CD4) endocytosis, whereas anti-CD4 antibodies and phorbol esters did. 29 Binding inhibition for superinfection was tested in the HIV experiment.
MuLV MuLV One of the two transgenic strains expressed three to nine times more transgene RNA and protein than the other strain. The former strain of mice were completely resistant to FLV-induced leukemia, while the latter mice were only partially resistant. This finding of Fv-4' gene expression dependent FLV-resistance in transgenic Fv-4' mice is consistent with our observation in the present study using mixed bone marrow chimeras. Further study may be necessary to clarify the precise mechanism whereby FLV resistance depends on the amount of Fv-4' env antigen on the cell surface.
In the mixed chimeras examined in the present study, the amount of Fv-4' env antigen on PBMC lacking the Fv-4' gene (C3H-derived) appeared highest at l month after bone marrow transplantation and then gradually decreased. As shown by the binding assay, serum of C4W + C3H chimeras contained more Fv-4' env antigen than the C4W serum. This finding may be due to increased proliferation or metabolic activity of bone marrow cells after bone marrow transplantation following supralethal irradiation.
Bone marrow transplantation has offered therapeutic prospects for the treatment of otherwise fatal hematologic malignancie~,'','~ severe combined imm~nodeficiency,~~ as well as aplastic anemia.3s However, the indication of bone marrow transplantation for retroviral infection is still The fact that the soluble or secreted form of viral env appeared to be effective in conferring resistance is auspicious for attempts to establish receptor interference therapy of retrovirus diseases by bone marrow transplantati~n'~~~' or other treatments, because (1) the transfected env gene might not need to be expressed in all marrow-derived cells, and (2) soluble forms of genetically engineered env proteins could be applicable for the therapy. Several approaches to block infection by soluble env or receptor proteins at the level of viral attachment to the cellular receptor have been reported. With HIV in vitro, soluble, secreted forms of the CD4 antigen3' and synthetic peptide segments of the CD4 m~lecule'~ have been shown to block HIV infection of CD4-positive cells. Moreover, anti-CD4 antibody4' and phorbol esters" induce internalization of the CD4 molecule resulting in a block to HIV binding. HIV-like particles containing modified envelope glycoproteins were used to develop a crossprotective AIDS vaccine in vivo.4' However, the efficacy of soluble CD4 or anti-CD4 antibody therapy, as well as vaccine therapy of AIDS, is still controversial. CD4 epitope masking by envelope protein could also downregulate CD4-positive cell function.42 Nevertheless, the unique interference mechanism of an env gene product shown in this study could contribute to establishing a novel basis for therapeutic intervention in AIDS.
